Description of Business Maravai LifeSciences Holdings, Inc. (also referred to in this document as Maravai, we, us, our or the Company) is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Our customers include biopharmaceutical companies, emerging biotech firms, life science research organizations, academic research institutions and diagnostics companies. Our compreh...
Q2 FY2026 — expected 2026-08-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001823239-26-000011 | EDGAR | 84K words |
| 2025-03-18 | 2024-12-31 | 0001823239-25-000034 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001823239-24-000032 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001823239-23-000014 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001823239-22-000012 | EDGAR | — |
| 2021-03-22 | 2020-12-31 | 0001823239-21-000006 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001823239-26-000059 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001823239-25-000120 | EDGAR | 36K words |
| 2025-08-11 | 2025-06-30 | 0001823239-25-000107 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001823239-25-000063 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001823239-24-000118 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001823239-24-000095 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001823239-24-000060 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001823239-23-000089 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001823239-23-000081 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001823239-23-000039 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001823239-22-000058 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0001823239-22-000044 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001823239-26-000056 | EDGAR | — |
| 2026-02-25 | 0001823239-26-000005 | EDGAR | 6K words |
| 2025-11-06 | 0001823239-25-000117 | EDGAR | — |
| 2025-10-27 | 0001823239-25-000113 | EDGAR | — |
| 2025-08-11 | 0001823239-25-000105 | EDGAR | — |
| 2025-07-18 | 0001823239-25-000099 | EDGAR | — |
| 2025-06-25 | 0001193125-25-146905 | EDGAR | — |
| 2025-06-09 | 0001193125-25-137478 | EDGAR | — |
| 2025-05-28 | 0001823239-25-000065 | EDGAR | — |
| 2025-05-12 | 0001823239-25-000062 | EDGAR | — |
85 total filings indexed. 57 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001823239 |
| Ticker | MRVI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.maravai.com |
| Listed | 2020-11-20 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MRVI (~200 tokens, structured JSON with cryptographic provenance)